Market Context — Why This Technology, Why Now

The global market for health and wellness products is experiencing robust growth, fueled by consumer demand for proactive health management and performance enhancement. Regulatory bodies are increasingly scrutinizing efficacy claims, favoring science-backed solutions. This technology, with its validated mechanism for PPARδ activation, is perfectly positioned to meet these demands, offering a competitive edge in functional ingredients and therapeutic development for metabolic and performance-related health.

Key Competitive Advantages
01

Activates PPARδ via a novel mechanism, potentially offering superior physiological activity compared to existing compounds.

02

Secures robust patent rights in a highly competitive field, overcoming 13 cited prior art documents, ensuring strong market differentiation.

03

Offers broad applicability, improving exercise endurance and aiding in the treatment/prevention of metabolic disorders, enabling diverse product development.

Market Opportunity
Functional Foods & Supplements
$5B–$10B globally (AI est.)
This technology could provide new added value to the existing market with products appealing to health-conscious consumers, focusing on improved exercise performance, fatigue recovery, and metabolic enhancement.
Major food and beverage corporations Dietary supplement manufacturers Health and wellness product developers
Pharmaceuticals (Metabolic Disorders)
$5B–$10B globally (AI est.)
This technology has the potential to address unmet medical needs as a novel therapeutic candidate for metabolic disorders such as diabetes, dyslipidemia, and non-alcoholic steatohepatitis (NASH).
Pharmaceutical companies specializing in metabolic diseases Biotech firms developing novel therapeutics Contract research organizations (CROs) for drug development
Sports Nutrition
$500M–$1B globally (AI est.)
This technology could see high demand for evidence-based products targeting both professional and amateur athletes aiming to improve exercise endurance and achieve efficient body composition.
Sports nutrition brands Performance supplement companies Professional athletic organizations
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a broad scope of PPARδ activators and exercise endurance enhancers, specifically covering certain guanidine or biguanidine derivatives as active ingredients. It successfully navigated a rigorous examination process, overcoming multiple rejections and 13 cited prior art documents, indicating a robust and defensible right.

Competitive White Space

This patent focuses on specific guanidine/biguanidine derivatives as PPARδ activators. White space exists in developing novel delivery systems, combination therapies with other compounds, or exploring applications in non-metabolic/exercise-related fields.

Economic Impact
~$20M/year estimated new market creation potential (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

If this technology is introduced into the functional food and supplement market, targeting products that enhance exercise performance and improve metabolism, it is estimated to create a new market potential of ~$20M annually (AI est.). This projection assumes capturing a segment of the existing market (e.g., 1% of the domestic market size, estimated at ~$20B globally (AI est.)), driven by increasing health consciousness and the healthcare market's 6% annual CAGR.

Speed to Market
3× faster than in-house development
Developing a novel PPARδ activator in-house typically requires over 5 years and substantial investment. Licensing this patent could reduce the development timeline to approximately 2 years, as the mechanism of action and active ingredient backbone are established. This allows for leveraging existing preclinical data and applying established safety protocols, significantly compressing time-to-market and reducing development risk due to its academic origin.
Competitive Positioning

X: Breadth of Physiological Activity
Y: Development Speed & Certainty

Business Models & Applications
🧪 Functional Ingredient Licensing
License the active ingredients to food and supplement manufacturers as functional raw materials. This model allows for monetization through royalty income and collaborative R&D.
💊 Pharmaceutical Co-Development
Collaborate with pharmaceutical companies to co-develop novel drugs for metabolic or musculoskeletal disorders. This model aims for high post-launch profits while sharing development risks.
🏭 OEM/ODM Supply
Provide contract manufacturing and supply of final products utilizing this technology. This supports licensees in rapidly entering the market with their own branded products.
Adjacent Application Opportunities
🐾 Pet Healthcare
Animal Exercise & Metabolic Support Supplements
Develop animal supplements leveraging this technology to address declining mobility and obesity in aging dogs and cats. This could improve pet quality of life and meet owner demand, with potential for metabolic benefits across various breeds.
🔬 Research Reagents & Tools
PPARδ Activator for Research Applications
Offer the active ingredients as reagents for PPARδ functional analysis and novel drug screening to academic institutions and pharmaceutical R&D. This could contribute to basic research advancements and establish a new revenue stream in the research market, estimated at ~$500M globally (AI est.).
🧴 Cosmetics & Beauty
Skin Metabolism & Anti-Aging Ingredients
PPARδ may be involved in skin cell metabolism. This technology could be applied to develop cosmetic ingredients that promote skin cell turnover and offer anti-aging effects, targeting the premium beauty market, valued at over ~$100B globally (AI est.).
Integration Roadmap — Estimated 36-Month Deployment
Phase 1: Technology Evaluation & Compound Optimization
Duration: 6 months
Detailed verification of the active ingredient's mechanism of action and consistency with existing data. Conduct fine-tuning of compound structure and stability tests to match target market needs.
Phase 2: Prototype Development & Safety Evaluation
Duration: 12 months
Develop prototype formulations for functional foods, supplements, or pharmaceutical candidates. Simultaneously conduct in vitro/in vivo safety tests and efficacy evaluations in animal models.
Phase 3: Clinical Trials & Commercialization Prep
Duration: 18 months
Initiate human clinical trials (PoC acquisition, safety/efficacy confirmation). Prepare for regulatory applications, establish manufacturing processes, and formulate market launch strategies.
Technical Feasibility
The active ingredients, guanidine or biguanidine derivatives, are manufacturable using existing organic synthesis techniques, suggesting relatively low technical hurdles for production. The patent claims clearly define specific structures, facilitating compound design and evaluation. Integration into existing pharmaceutical and food manufacturing lines is expected to be smooth by adding a new active ingredient blending process. Overall, technical feasibility is considered high using general evaluation systems.
Success Scenario
Adopting this technology could enable licensees to rapidly launch new product lines aimed at improving exercise function and metabolic disorders. For instance, within three years, functional sports drinks or supplements targeting health-conscious consumers could capture several percentage points of market share, potentially increasing annual sales by 1.5 times compared to current product portfolios. This could enhance brand value, attract new customer segments, and strengthen long-term revenue streams.
Patent Record
APPLICATION NO.
特願2020-553434
REGISTRATION NO.
7397491
FILING DATE
2019/10/23
GRANT DATE
2023/12/05
EXPIRATION DATE
2039/10/23
PATENT HOLDER
国立研究開発法人科学技術振興機構
Examination History
2021年03月25日
出願審査請求書
2022年04月19日
拒絶理由通知書
2022年08月16日
意見書
2022年08月16日
手続補正書（自発・内容）
2022年12月13日
拒絶理由通知書
2023年04月10日
意見書
2023年04月10日
手続補正書（自発・内容）
2023年06月20日
拒絶査定
2023年09月14日
早期審理に関する事情説明書
2023年09月14日
手続補正書（自発・内容）
2023年09月26日
審査前置移管
2023年10月03日
審査前置移管通知
2023年10月24日
特許査定
2023年10月27日
審査前置登録